Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,763.25
(
0.35%
)
News Focus
News Focus
Post# of 129715
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

swampboots

Send PM Follow Ignore
Followers 179
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

swampboots

Re: maxluke1 post# 98898

Thursday, 07/07/2022 12:03:09 PM

Thursday, July 07, 2022 12:03:09 PM

Post# of 129715
NEXI: I like DTIL better 1.53, both do allogeneic cell therapy,, both have some insider buying, but DTIL has revenue ,partners and cash to 2024 as just did the dilutive pipe sure shot dive.
I am no scientist so have to believe Novartis and Lilly picked over the important substance only computation rigor could discern.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now